Welltower Inc. (WELL), one of the largest healthcare real estate investment trusts, reported second-quarter 2026 results on July 27, 2026, after the market close. The company owns a large portfolio of senior housing, post-acute care, and outpatient medical properties across the United States, Canada, and the United Kingdom. This release stood out because the senior housing sector continues to benefit from strong demographic trends—an aging population, higher healthcare spending among older adults, and limited new supply. Welltower’s shift toward the Seniors Housing Operating segment and its acquisition activity made the quarter a meaningful checkpoint on whether the company can maintain its growth trajectory.
Welltower delivered normalized funds from operations of $1.60 per diluted share, above the Zacks Consensus Estimate of $1.55 and up 25.0% from $1.28 in the same quarter last year. This marks the fourth straight quarter of beating consensus FFO estimates. On a GAAP basis, net income attributable to common stockholders was $0.61 per diluted share, compared with $0.45 a year earlier.
Revenue totaled $3.54 billion, a 39.1% increase year-over-year that exceeded the consensus range of roughly $3.36–$3.43 billion. Growth was supported by the Amica Senior Lifestyles acquisition, which closed on April 1, 2026, and added 38 Canadian seniors housing communities for a pro rata purchase price of C$4.1 billion.
The most notable operational figure was total portfolio same-store NOI growth of 15.5%, led by 20.5% growth in the SHO portfolio. Within SHO, same-store revenue rose 9.2%, helped by a 330-basis-point occupancy gain and 5.2% RevPOR growth. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Shares of WELL closed the regular session at $248.80, down about 1.3%, as some investors waited for the print. After hours the stock rose more than 4% and traded above $258 once the FFO beat, higher guidance, and 15% dividend increase to $0.85 per share were announced. The updated full-year normalized FFO range of $6.36–$6.44 per share (from $6.21–$6.35) showed management’s confidence in the growth outlook. With the stock already up roughly 36% year-to-date and about 57% over the past twelve months, the reaction indicates investors see the results as supporting the premium valuation relative to other REITs.
Welltower enters the second half of 2026 with solid momentum. The raised guidance points to continued double-digit FFO growth, and the dividend increase underscores management’s outlook. Several areas will be important to monitor. Integration and performance of the Amica portfolio in Canada will be watched closely, including occupancy and RevPOR trends in those communities. The ongoing shift away from the $7.2 billion Outpatient Medical portfolio through additional dispositions will affect capital allocation and future NOI growth. The balance sheet remains supportive, with Net Debt to Adjusted EBITDA at 2.99x and roughly $9.5 billion in liquidity as of June 30, 2026. The recent issuance of C$1.15 billion in senior unsecured notes at a 3.95% weighted-average coupon provides additional flexibility. Broader industry conditions also remain favorable, with senior housing occupancy reaching about 89.9% in the second quarter and new supply staying near historic lows. Potential headwinds include higher interest costs, labor pressures, and the challenge of sustaining elevated growth rates at larger scale.
When evaluating REITs like WELL or screening for similar healthcare real estate opportunities, I occasionally turn to Tickeron’s AI Screener. It helps filter stocks by industry, technical signals, and other criteria without manually reviewing dozens of charts. The tool has proven useful for quickly identifying names with comparable momentum characteristics.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
WELL saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 19, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In 22 of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 52%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 27 of 62 cases where WELL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 44%.
The Momentum Indicator moved below the 0 level on November 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on WELL as a result. In 34 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 44%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WELL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 48%.
WELL broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for WELL entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
WELL moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for WELL crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 54%.
Following a +1.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where WELL advanced for three days, in 229 of 355 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 32 (best 1 - 100 worst), indicating outstanding price growth. WELL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.804) is normal, around the industry mean (3.134). WELL has a moderately high P/E Ratio (110.365) as compared to the industry average of (30.791). WELL's Projected Growth (PEG Ratio) (3.660) is slightly higher than the industry average of (1.649). Dividend Yield (0.014) settles around the average of (0.050) among similar stocks. WELL's P/S Ratio (13.316) is slightly higher than the industry average of (6.013).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a real estate investment trust
Industry PublishingBooksMagazines